Pietro Scalfaro,Jean-Maurice Dumont,Gregoire Vuagniaux,Rolland-Yves Mauvernay
申请号：
US12915370
公开号：
USRE043371E1
申请日:
2010.10.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.
